Editorial: Drugging p53 for non-cancer diseases.

Saved in:

Bibliographic Details
Title:	Editorial: Drugging p53 for non-cancer diseases.
Authors:	Jiang F; Shandong Key Laboratory of Cardiovascular Proteomics and Department of Geriatric Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China., Li CG; NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia., Seto SW; NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia.; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong SAR, China.; Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Source:	Frontiers in pharmacology [Front Pharmacol] 2022 Nov 30; Vol. 13, pp. 1101742. Date of Electronic Publication: 2022 Nov 30 (Print Publication: 2022).
Publication Type:	Editorial
Journal Info:	Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

FullText	Links: – Type: pdflink Text: Availability: 0
Header	DbId: mdl DbLabel: MEDLINE Ultimate An: 36532782 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0
IllustrationInfo
Items	– Name: Title Label: Title Group: Ti Data: Editorial: Drugging p53 for non-cancer diseases. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jiang+F%22">Jiang F</searchLink>; Shandong Key Laboratory of Cardiovascular Proteomics and Department of Geriatric Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Li+CG%22">Li CG</searchLink>; NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Seto+SW%22">Seto SW</searchLink>; NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia.; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong SAR, China.; Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Hong Kong SAR, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 Nov 30; Vol. 13, pp. 1101742. <i>Date of Electronic Publication: </i>2022 Nov 30 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink	https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36532782
RecordInfo	BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2022.1101742 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1101742 Titles: – TitleFull: Editorial: Drugging p53 for non-cancer diseases. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jiang F – PersonEntity: Name: NameFull: Li CG – PersonEntity: Name: NameFull: Seto SW IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 11 Text: 2022 Nov 30 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in pharmacology Type: main
ResultId	1